


Genetic Circuit Therapeutics Email Formats
Biotechnology Research • • 1-10 Employees
Key Contact at Genetic Circuit Therapeutics
Dylan Paoletti
Co-Founder & CEO
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
About Genetic Circuit Therapeutics
Genetic Circuit Therapeutics is a biotechnology company pioneering the next generation of cancer treatments using synthetic biology. We design and engineer gene circuits, which are programmable genetic systems that respond to cellular signals, to create highly selective and powerful therapies for aggressive cancers like skin cancer and small cell lung carcinoma. Our core technology leverages synthetic gene networks that detect specific cancer markers and activate therapeutic responses only in cancerous cells. By combining molecular biology, genetic engineering, and systems design, our therapies aim to reduce off-target effects, lower toxicity, and improve outcomes for patients. Founded by a team of young scientists and innovators, Genetic Circuit Therapeutics is currently in the research and development phase. Our mission is to reprogram biology to treat cancer with greater precision, offering patients smarter and safer alternatives to traditional therapies.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Genetic Circuit Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Genetic Circuit Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



